EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Clinical Evaluation of the Hemostatic Efficacy and Safety of a Biodegradable Hemostatic Agent, Hemogram: A Comparative Study with Arista™ AH

Seung Ki Min iD, Sung Eun Oh, Ji Yeong An, Hyun Kyoon Kim, Eun Jin Kim, Min-Gew Choi

Clinical and Applied Thrombosis/Hemostasis · 2026

DOI: 10.1177/10760296251405423 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, 2026. Verfasst von Seung Ki Min und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea. Hauptthemen laut MEDLINE: Hemostatics, Gastrectomy. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hemogram is a novel biodegradable powdered hemostatic agent developed by binding calcium ions (Ca² + ) to carboxymethyl starch (CM-starch) and applying granulation technology to enhance blood absorption and hemostatic efficacy. This study aimed to evaluate the clinical efficacy and safety of Hemogram compared with the commercially available agent Arista™ AH in patients undergoing gastrectomy.

Methods

This randomized controlled trial was conducted at Samsung Medical Center and included patients who experienced intraoperative oozing-type bleeding during gastrectomy. A total of 64 patients were enrolled and evenly randomized to receive either Hemogram (n = 32) or Arista™ AH (n = 32) for local hemostasis. The primary efficacy endpoint was the hemostatic success rate within 5 min. Secondary endpoints included hemostasis time, re-bleeding rate, number of hemostatic agent units used, transfusion volume, length of hospital stay, and incidence of adverse events.

Results

Hemostatic success within 5 min was achieved in 100% (32/32) of the Hemogram group and 96.9% (31/32) of the Arista™ AH group, with no statistically significant difference between the two (P > 0.05). The mean time to hemostasis was 1.25 ± 0.80 min in the Hemogram group and 1.52 ± 0.85 min in the Arista™ AH group. No re-bleeding events were observed in the Hemogram group, while one case of re-bleeding (3.3%) was reported in the Arista™ AH group. There were no significant differences between groups in terms of transfusion volume, length of hospitalization, or adverse event rates.

Conclusion

Hemogram demonstrated non-inferior hemostatic efficacy and safety compared to Arista™ AH in patients undergoing gastrectomy. These findings suggest that Hemogram is a promising and clinically applicable hemostatic agent for surgical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemostaticsGastrectomyHumansMaleFemaleMiddle AgedAgedAdultHemostasisTreatment Outcome

Stichwörter der Autor:innen

bleedingcarboxymethyl starchhemostatic agentintra-abdominal surgery

Substanzen

Hemostatics

Autor:innen und Institutionen

  • Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea.
  • Theracion Biomedical Co., Ltd, Seongnam, Gyeonggi 13207, South Korea.

ORCID-Profile: Seung Ki Min

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare

Zitieren

APA

Min, S. K., Oh, S. E., An, J. Y., Kim, H. K., Kim, E. J., & Choi, M. G. (2026). Clinical Evaluation of the Hemostatic Efficacy and Safety of a Biodegradable Hemostatic Agent, Hemogram: A Comparative Study with Arista™ AH. Clinical and Applied Thrombosis/Hemostasis. https://doi.org/10.1177/10760296251405423

Vancouver

Min SK, Oh SE, An JY, Kim HK, Kim EJ, Choi MG. Clinical Evaluation of the Hemostatic Efficacy and Safety of a Biodegradable Hemostatic Agent, Hemogram: A Comparative Study with Arista™ AH. Clinical and Applied Thrombosis/Hemostasis. 2026. doi:10.1177/10760296251405423

BibTeX
@article{Min2026,
  author = {Min, Seung Ki and Oh, Sung Eun and An, Ji Yeong and Kim, Hyun Kyoon and Kim, Eun Jin and Choi, Min-Gew},
  title = {Clinical Evaluation of the Hemostatic Efficacy and Safety of a Biodegradable Hemostatic Agent, Hemogram: A Comparative Study with Arista™ AH},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2026},
  doi = {10.1177/10760296251405423}
}
Kostenlos starten →